Nisa Investment Advisors
CCXI

Nisa Investment Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Nisa Investment Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,660
Closed -$66K – 2660
2022
Q2 		$66K Hold
2,660
– – ﹤0.01% 1644
2022
Q1 		$67K Sell
2,660
-2,228
-46% -$62.6K ﹤0.01% 1754
2021
Q4 		$131K Buy
4,888
+1,558
+47% +$54.7K ﹤0.01% 1416
2021
Q3 		$57 Hold
3,330
– – ﹤0.01% 1906
2021
Q2 		$45 Buy
3,330
+1,200
+56% +$29.6K ﹤0.01% 1971
2021
Q1 		$109 Hold
2,130
– – ﹤0.01% 1718
2020
Q4 		$132K Buy
2,130
+350
+20% +$20K ﹤0.01% 1626
2020
Q3 		$98K Buy
1,780
+1,350
+314% +$72.7K ﹤0.01% 1552
2020
Q2 		$25K Buy
430
+100
+30% +$5.44K ﹤0.01% 1739
2020
Q1 		$13K Buy
+330
New +$14K ﹤0.01% 1810

Other funds holding CCXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Nisa Investment Advisors's CCXI Position: Q3 2022 in Review

Nisa Investment Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 2,660 shares — an estimated $66K sold.

Nisa Investment Advisors first reported a position in CCXI in Q1 2020 and held it in 10 quarters. The position peaked at $132K in Q4 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

  • Nisa Investment Advisors reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 2,660 ChemoCentryx, Inc. shares in Q3 2022, an estimated $66K.
  • Nisa Investment Advisors first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 10 quarters.
  • Nisa Investment Advisors's ChemoCentryx, Inc. position peaked at $132K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Nisa Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.